Education
About Us
Working with TipRanks
Follow Us
Ibio Inc (IBIO)
NASDAQ:IBIO
IBIO Stock Chart & Stats
$1.25
-$0.02(-0.74%)
At close: 4:00 PM EST
$1.25
-$0.02(-0.74%)
Day’s Range― - ―
52-Week Range$0.56 - $6.89
Previous CloseN/A
Volume55.53K
Average Volume (3M)5.75M
Market Cap
$26.13M
Enterprise ValueN/A
Total Cash (Recent Filing)$8.58M
Total Debt (Recent Filing)$3.51M
Price to Earnings (P/E)―
Beta1.19
Next Earnings
Feb 16, 2026EPS Estimate
-0.07Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-0.11
Shares Outstanding20,254,599
10 Day Avg. Volume3,747,766
30 Day Avg. Volume5,749,966
Financial Highlights & Ratios
PEG Ratio<0.01
Price to Book (P/B)0.54
Price to Sales (P/S)20.03
P/FCF Ratio-0.52
Enterprise Value/Market Cap0.00
Enterprise Value/Revenue0.00
Enterprise Value/Gross Profit0.00
Enterprise Value/Ebitda0.00
Forecast
1Y Price Target
$3.90Price Target Upside212.00% Upside
Rating ConsensusStrong Buy
Number of Analyst Covering4
EPS Forecast (FY)N/A
Revenue Forecast (FY)N/A
Ibio News
IBIO FAQ
What was Ibio Inc’s price range in the past 12 months?
Ibio Inc lowest stock price was $0.56 and its highest was $6.89 in the past 12 months.
What is Ibio Inc’s market cap?
Ibio Inc’s market cap is $26.13M.
When is Ibio Inc’s upcoming earnings report date?
Ibio Inc’s upcoming earnings report date is Feb 16, 2026 which is in 95 days.
How were Ibio Inc’s earnings last quarter?
Ibio Inc released its earnings results on Nov 12, 2025. The company reported -$0.11 earnings per share for the quarter, beating the consensus estimate of -$0.207 by $0.097.
Is Ibio Inc overvalued?
According to Wall Street analysts Ibio Inc’s price is currently Undervalued.
Does Ibio Inc pay dividends?
Ibio Inc does not currently pay dividends.
What is Ibio Inc’s EPS estimate?
Ibio Inc’s EPS estimate is -0.07.
How many shares outstanding does Ibio Inc have?
Ibio Inc has 20,254,599 shares outstanding.
What happened to Ibio Inc’s price movement after its last earnings report?
Ibio Inc reported an EPS of -$0.11 in its last earnings report, beating expectations of -$0.207. Following the earnings report the stock price went up 0.806%.
Which hedge fund is a major shareholder of Ibio Inc?
Currently, no hedge funds are holding shares in IBIO
Company Description
Ibio Inc
Ibio, Inc. is a biotechnology company specializing in the development and commercialization of innovative therapeutic and prophylactic products. The company focuses on plant-based protein expression technologies, offering solutions primarily in the pharmaceutical sector. Ibio's core products include biologics for various applications, including vaccines and therapeutic proteins, leveraging its proprietary FastPharming System to produce proteins in plants efficiently and at scale.
IBIO Stock 12 Month Forecast
Average Price Target
$3.90
▲(212.00% Upside)
Technical Analysis
Minerva Neurosciences
―
Pulmatrix
―
Chemomab Therapeutics
―
Aspire Biopharma Holdings
―
FibroBiologics, Inc.
―
Ownership Overview
1.25% Insiders
1.10% Mutual Funds
13.91% Other Institutional Investors
82.90% Public Companies and
Individual Investors
Options Prices
Currently, No data available
---